Friedberg Ezra M - Insider Non-Derivative Transactions at Chromocell Therapeutics Corp (CHRO) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Feb 21, 2024, Friedberg Ezra M's relationship to Chromocell Therapeutics Corp (CHRO) is Director, and currently has 545,721 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CHRO insiders.

Data Source: SEC.
Friedberg Ezra M - Insider Non-Derivative Transactions of CHRO Common Stock
Friedberg Ezra M - Insider Non-Derivative Transactions at CHRO
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Feb 22, 2024 M -- (Common Stock) 13649 4.8 513727
Feb 22, 2024 M -- (Common Stock) 6992 4.8 520719
Feb 22, 2024 P -- (Common Stock) 16667 6 545721